[wpbb post:title]

Past Forums

Artificial Intelligence

Boston
April 23-25, 2018

Cancer

Boston
April 25-27, 2016

Cardiovascular

Boston
May 1-3, 2017

Neuroscience

Boston
April 27-29, 2015

Neuroscience

London
March 27, 2017

Past Forum Keynoters

CEOs

• Jani Ahonala
  CEO, Noona Healthcare
• Stéphane Bancel
  CEO, Moderna Therapeutics
• George Barrett
  CEO, Cardinal Health
• Fabien Beckers, PhD
  CEO, Arterys
• Mark Bertolini
  CEO, Aetna
• Katrine Bosley
  CEO, Editas Medicine
• Robert Bradway
  CEO, Amgen
• Nancy Brown
  CEO, American Heart Association
• Dan Burton
  CEO, Health Catalyst
• Giovanni Caforio, MD
  CEO, Bristol-Myers Squibb
• Robert Califf, MD
  Commissioner (former), Food and Drug Administration
• Peter Chiarelli
  CEO, One Mind for Research
• Tony Coles, MD
  CEO, Yumanity Therapeutics
• Patrick Conway, MD
  CEO, BCBS of North Carolina
• Marc de Garidel
  CEO, Ipsen
• Louis DeGennaro, PhD
  President and CEO, The Leukemia & Lymphoma Society
• Susan Dentzer
  CEO, Network for Excellence in Health Innovation
• Keith Dionne, PhD
  CEO, Constellation Pharmaceuticals
• Deborah Dunsire, MD
  CEO, XTuit Pharmaceuticals
• Helmy Eltoukhy, PhD
  CEO, Guardant Health
• Maurice Ferre, MD
  CEO, Insightec
• Frank Fischer
  CEO, NeuroPace
• John Flannery
  CEO, GE Healthcare
• Paul Fonteyne
  CEO, Boehringer-Ingelheim USA
• Peter Ford
  Founder and CEO, Control Bionics
• Richard Gonzalez
  CEO, AbbVie
• Colin Hill
  CEO, GNS Healthcare
• Andew Hopkins
  CEO, Exscientia
• Jensen Huang
  CEO, NVIDIA
• Thomas Hughes, PhD
  CEO, Zafgen
• Jackie Hunter, PhD
  CEO, Benevolent AI
• Jeff Immelt
  CEO, General Electric
• Omar Ishrak, PhD
  CEO, Medtronic
• Joseph Jachinowski
  CEO, Mevion Medical Systems
• Joseph Jimenez
  CEO, Novartis
• Karim Karti
  CEO, GE Healthcare Imaging
• Krishna Kumar
  CEO, Emerging Businesses, Philips
• John Lechleiter, PhD
  Chairman, Eli Lilly and Company
• David Lee
  CEO, Lumicell
• Jeffrey Leiden, MD, PhD
  CEO, Vertex Pharmaceuticals
• Noga Leviner
  CEO, Picnic Health
• Michael Mahoney
  CEO, Boston Scientific
• John Maraganore, PhD
  CEO, Alnylam
• Corey McCann, MD, PhD
  Founder and CEO, Pear Therapeutics
• Martin McGlynn
  CEO, StemCells
• Clive Meanwell, MD, PhD
  CEO, The Medicines Company
• David Meeker, MD
  CEO, Genzyme
• Michael Minogue
  CEO, Abiomed
• Bernd Montag, PhD
  CEO, Siemens Healthineers
• Briggs Morrison, MD
  CEO, Syndax Pharmaceuticals
• Robert Mulroy
  CEO, Merrimack Pharmaceuticals
• Michael Mussallem
  CEO, Edwards Lifesciences
• Vasant Narasimhan, MD
  CEO, Novartis
• Diana Nole
  CEO, Wolters Kluwer Health
• Gabriel Otte
  CEO, Freenome
• Michael Pellini, PhD
  CEO, Foundation Medicine
• Gary Reedy
  CEO, American Cancer Society
• Jonathan Rennert
  CEO, ZOLL Medical
• Paul Ricci
  Former Chairman and CEO, Nuance Communications
• Timothy Ring
  CEO, Bard
• Johnathan Rothberg, PhD
  Founder and CEO, Butterfly Network
• Judy Salerno, MD
  CEO, Susan G. Komen for the Cure
• Satish Sanan
  CEO, Inspirata
• George Scangos, PhD
  CEO, Biogen
• Dale Schenk, PhD
  CEO, Prothena
• Todd Sherer, PhD
  CEO, The Michael J. Fox Foundation for Parkinson’s Research
• Sue Siegel
  CEO, GE Ventures & healthymagination
• Nancy Simonian, MD
  CEO, Syros Pharmaceuticals
• Punit Soni
  CEO, Robin AI
• David Torchiana, MD
  CEO, Partners HealthCare
• Steven Tregay, PhD
  CEO, Forma Therapeutics
• Chuck Wilson, PhD
  CEO, Unum Therapeutics
• Dow Wilson
  CEO, Varian Medical Systems
• Frans van Houten
  CEO, Philips

Executives, Investors, Philanthropic and Government Leads

• Amy Abernethy, MD, PhD
  CMO, CSO & SVP Oncology, Flitiron Health
• Philip Adamson, MD
  VP and Medical Director, Abbott
• Julia Beaver, MD
  Acting Clinical Team Leader, Division of Oncology Products 1, CDER, FDA
• Roy Beveridge, MD
  SVP and CMO, Humana
• Morris Birnbaum, MD, PhD
  SVP and CSO, CVMET, Pfizer
• Daniel Bloomfield, MD
  SVP, Global Clinical Research, Therapeutic Area Head, Cardiometabolic & Womens Health, MRL Lead, China R&D, Merck
• Jay Bradner, MD
  President, Novartis Institutes for Biomedical Research
• Troy Brennan, MD
  EVP and CMO, CVS Health
• Terri Bresenham
  Chief Innovation Officer, GE Healthcare
• Carsten Brunn, PhD
  Head of Pharmaceuticals, Americas Region, Bayer
• Iain Buchan, MD
  Director of Healthcare Research, Microsoft Research
• Hon, Sylvia Mathews Burwell
  Secretary, U.S. Health and Human Services
• Doug Cole, MD
  General Partner, Flagship Ventures
• Meryl Comer
  President, Geoffrey Beene Foundation Alzheimer’s Initiative
• Robert Copeland, PhD
  President, Research and CSO, Epizyme
• Newt Crenshaw
  VP, North America Oncology, Eli Lilly and Company
• Francis Cuss, MD
  EVO and CSO, R&D, Bristol-Myers Squibb
• Leonard D’Avolio, PhD
  CEO, Cyft, Inc.
• Michael Dale
  Divisional VP and General Manager, Structural Heart, Abbott
• Thomas Daniel, MD
  Chairman, Celgene Research
• Jens Eckstein, PhD
  President, SR One
• Steve Fawell, PhD
  VP, Head Oncology iScience, AstraZeneca
• Robert Ford
  EVP, Medical Devices, Abbott
• Jean-François Formela, MD
  Partner, Atlas Venture
• Colleen Fowler
  VP, GM, AF Solutions, Medtronic
• Pete Frates
  Champion, ALS Ice Bucket Challenge
• Jamie Freedman, MD, PhD
  SVP, Global Clinical Development, Medimmune
• Mark Frohlich, MD
  EVP, Portfolio Strategy, Juno Therapeutics
• Gary Gibbons, MD
  Director, National Heart,&bnsp;Lung, and Blood Institute (NHLBI)
• Kathy Giusti
  Founder, MMRF and Multiple Myeloma Research Consortium
• Corey Goodman, PhD
  Managing Partner, venBio
• Jeffrey Gulcher, MD, PhD
  President and CSO, NextCODE Health
• Adele Gulfo
  EVP & Head, Global Commercial Development, Mylan; Director, Bemis, Inc.
• Atul Gawande, MD
  Ariadne Labs; Samuel O. Thier Professor of Surgery, HMS; Surgeon, BWH
• Sean Harper, MD
  EVP, R&D, Amgen
• Seth Hain
  Director, Analytics & Machine Learning, Epic
• William Hait, MD, PhD
  Global Head, Janssen Research & Development, J&J
• Ludovic Helfgott
  Global VP, Cardiovascular, Renal and Metabolism, AstraZeneca
• Paul Hudson
  President, AstraZeneca US and EVP, North America
• Michael Hutton, PhD
  CSO, Neurodegenerative Diseases, Eli Lilly and Company
• Rajiv Kaul
  Select Biotechnology Portfolio and Advisor Biotechnology Fund, Fidelity Investments
• Hiroyuki Kawabata
  Director, Health & Welfare Department, JETRO New York
• Allison Kean, MD
  CV Therapeutic Area Lead, Global Business Development, Pfizer
• John Kelly, PhD
  SVP, Cognitive Solutions and Research, IBM
• Aarif Khakoo, MD
  VP Research, Cardiometabolic Disorders Therapeutic Area Head, Site Head Amgen San Francisco, Amgen
• Maria Koehler, MD, PhD
  VP, Strategy, Innovation and Collaborations, Pfizer Oncology Business Unit
• Lothar Krinke, PhD
  VP and GM, Brain Modulation, Medtronic
• Paul LaViolette
  Managing Partner and COO, SV Life Sciences Advisers
• Peter Lebowitz, MD, PhD
  Global Therapeutic Area Head, Oncology, Janssen R&D
• Jonathan Leff
  Partner, Deerfield Management
• Gillian Leng, MD
  Deputy Chief Executive, Director of Health and Social Care, National Institute for Health and Care Excellence
• John Lepore, MD
  SVP, R&D Pipeline, GlaxoSmithKline
• Dean Li, MD, PhD
  VP, Head Translational Medicine, Merck
• Geoffrey Ling, MD, PhD
  Director, Biological Technologies Office, DARPA
• Thomas Lynch, MD
  EVP and CSO, R&D, Bristol-Myers Squibb
• Lisa Maki
  Co-Founder, Director, PokitDok
• Misti Malone, PhD
  Chief, Peripheral Interventional Devices Branch, Food and Drug Administration
• Shaden Marzouk, MD
  CMO, Cardinal Health
• Henry McCance
  Chairman Emeritus, Greylock Partners, CO-Founder, Cure Alzheimer’s Fund
• Jessica Mega, MD
  CMO, Verily
• Professor Ian Meredith, PhD
  EVP, Global CMO, Boston Scientific
• Jeff Mirviss
  SVP and President, Peripheral Interventions, Boston Scientific
• Greg Moore, MD, PhD
  VP, Healthcare, Google Cloud
• Ryuichi Morishita, MD, PhD
  Founder, AnGes
• Alan Moses, MD
  SVP, Global CMO, Novo Nordisk
• Mark Murcko, PhD
  CSO, Relay Therapeutics
• Amir Nashat, PhD
  Managing Partner, Polaris Partners
• Peter Orszag, PhD
  Vice Chairman, Investment Banking and Managing Director, Lazard Freres
• Vijay Pande
  Partner, Andreessen Horowitz
• Georgia Papathomas, PhD
  SVP, Global Head of Data Sciences, Johnson & Johnson
• Ora Pescovitz, MD
  SVP and US Medical Leader, Eli Lilly and Company
• Jonathan Plehn, MD
  VP Cardiovascular Medicine, Covance
• Miri Polachek
  Executive Director, Israel Brain Technologies
• Amy Pollack, MD
  CMO & VP Global Medical Affairs for the Early Technologies Business Group/Minimally Invasive Technology Innovations (MITG), Medtronic
• Sy Pretorius, MD
  SVP & CSO, PAREXEL International
• David Reese, MD
  SVP, Translational Sciences, Amgen
• Alessandro Riva, MD
  Global Head, Oncology Development and Medical Affairs, Novartis Oncology
• James Robinson
  President, Americas Operations, Astellas
• Ann Romney
  Global Ambassador, Ann Romney Center for Neurologic Diseases at Brigham and Women’s Hospital
• Bruce Rosengard, MD
  Chief Medical Science and Technology Officer, Johnson & Johnson Medical Devices Companies
• Michael Rousseau
  President, Cardiovascular and Neuromodulation, Abbott
• Sean Salmon
  SVP and President, Coronary & Structural Heart, Medtronic
• Alfred Sandrock, MD, PhD
  Group SVP, CMO, Biogen
• Lewis Sandy, MD
  EVP, Clinical Advancement, UnitedHealth Group
• Joseph Scheeren, PharmD
  Senior Advisor, R&D, Bayer
• Darryle Schoepp, PhD
  VP and Therapeutic Area Head, Neuroscience Early Development and Discovery Sciences, Merck Research Laboratories
• William Sellers, MD
  VP and Global Head of Oncology, Novartis Institutes for BioMedical Research
• Sue Siegel
  CIO and CEO, Business Innovations, GE
• Andy Slavitt
  Acting Administrator, CMS
• Craig Sponseller, MD
  CMO, Kowa Pharmaceuticals America
• Norman Stockbridge, MD, PhD
  Director, Division of Cardiovascular and Renal Products, Food and Drug Administration
• Bruno Strigini
  President, Novartis Oncology
• Tamara Syrek Jensen
  Director, Coverage and Analysis Group, CMS
• Eiji Tanaka, PhD
  President, Head of Global Business Development, Mitsubishi Tanabe Pharma Holdings America, Inc.
• Robert Tepper, MD
  Partner, Third Rock Ventures, Adjunct Professor, HMS
• Claire Thom, PharmD
  SVP, Global Oncology Development, Astellas
• James Topper, MD, PhD
  Managing General Partner, Frazier Healthcare Partners
• Susan Tousi
  SVP, Product Development, Illumina, Inc.
• Timothy Tuttle, PhD
  CTO, Cognitive Collaboration Group, Cisco
• Paul Underwood, MD
  Medical Director, Boston Scientific
• Mike Vasconcelles, MD
  CMO, Unum Therapeutics
• Ajay Verma, MD, PhD
  VP, Experimental Medicine, Biogen
• Christopher Viehbacher
  Managing Partner, Gurnet Point Capital
• Seema Verma
  Administrator, Centers for Medicare and Medicaid Services
• Jeff Walker
  Vice-Chair, United Nations Envoy’s Office for Health Finance and Malaria
• Scott Wasserman, MD
  VP, Global Development, Amgen

Popular Panels

2018 WMIF
Fireside Chat: Vasant Narasimhan, MD, CEO, Novartis

• Moderator: Gregg Meyer, MD, Chief Clinical Officer, PHS; Professor of Medicine, MGH and HMS
• Vasant Narasimhan, MD, CEO, Novartis

2015 WMIF
Gene Editing, Gene Therapy, and the Eye as a Gateway

• Moderator: Jennifer Joe, MD, CEO, Medstro, Editor-In-Chief, MedTech Boston
• Katrine Bosley, CEO, Editas Medicine
• Eric Pierce, MD, PhD, Director, Retinal Degenerations Service, Massachusetts Eye and Ear; Solman and Libe Friedman Associate Professor of Ophthalmology, Harvard Medical School
• Philip Gregory, D. Phil, Senior Vice President, Research and CSO, Sangamo BioSciences
• David Meeker, MD, CEO, Genzyme

2016 WMIF
Fireside Chat: Joseph Jimenez, CEO, Novartis

• Moderator: Gregg Meyer, MD, Chief Clinical Officer, Partners HealthCare
• Joseph Jimenez, CEO, Novartis

2016 WMIF
Immunotherapy I: Checkpoint Activation and Cancer Vaccines

• Moderator: Nir Hacohen, PhD, Immunologist, MGH Center for Immunology and Inflammatory Diseases, MGH Research Scholar, Associate Professor, Medicine, Harvard Medical School
• Thomas Daniel, MD, Chairman, Celgene Research
• Glenn Dranoff, MD, Global Head of Exploratory Immuno-Oncology, Novartis Institutes for Biomedical Research
• Robert Mulroy, President and CEO, Merrimack Pharmaceuticals
• David Reese, MD, Senior Vice President, Translational Sciences, Amgen
• Scott Rodig, MD, PhD, Associate Professor, BWH
• Arlene Sharpe, MD, PhD, Leader, Cancer Immunology, BWH, DFCI, George Fabyan Professor of Comparative Pathology, Harvard Medical School

2017 WMIF
1:1 Fireside Chat: Omar Ishrak, PhD, CEO, Medtronic

• Moderator: Paul LaViolette, Managing Partner & COO, SV Life Sciences Advisers
• Omar Ishrak, PhD, CEO, Medtronic

2018 WMIF
1:1 Fireside Chat: Jensen Huang, CEO, NVIDIA

• Introduction: Scott Sperling, Co-President, Thomas H Lee Partners; Chairman of the Board of Directors, PHS
• Moderator: Keith Dreyer, DO, PhD, Chief Data Science Officer, PHS; Vice Chairman, Radiology, MGH; Associate Professor, Radiology, HMS
• Jensen Huang, CEO, NVIDIA

View All